ZyVersa Therapeutics, Inc. Common Stock

ZyVersa Therapeutics Gains on Compassionate Use Approval

ZyVersa Therapeutics shares are trading higher after the company announced FDA authorizing Emergency Compassionate Use of its drug VAR 200 for a patient with ApoCII amyloidosis.